Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Laurence Zitvogel
Based on 32 articles published since 2010
(Why 32 articles?)
||||
Expertise Level
The expertise of Laurence Zitvogel ranks in the
  • Top 0.78%
  • ... of 124,615 published authors worldwide on Melanoma
  • ... from 2010 through 2020
  • ... based on contributions to 32 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Zitvogel, Laurence   ·   Zitvogel, L
Work Locations
Details
Most likely:    Institut Gustave Roussy      
2019
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands. · Department of Immuno-Oncology, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Pathology, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Biostatistics, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Department of Medicine, Service of Dermatology Gustave Roussy and University Paris-Sud. · INSERM U 1015, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · University Paris-Sud, Le Kremlin Bicetre, France. · Pubmed 31646109
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Medical Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Experimental Pharmacology Unit, Department of Translational Research, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA. · Department of Pathology and Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · The Angeles Clinic, Experimental Therapeutics Cedars Sinai Foundation, Los Angeles, CA, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · University of Chicago Medical Center, Chicago, IL, USA. · Oncology Department, UNIL-CHUV, Lausanne, Switzerland. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Institut de Cancérologie, Gustave Roussy Cancer Campus, Villejuif, Paris, France. · Refuge Biotechnologies, Menlo Park, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, 9609 Medical Center Drive, Bethesda, MD, 20892-7420, USA. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Pubmed 31331337
2018
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Department of Microbiology and Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France. · Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, and Department of Pharmacology, University of California San Diego, La Jolla, California. · Immunology and Virology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia, Crawley, Western Australia, Australia. · University Paris-Saclay, Kremlin Bicêtre, France. · CIC1428, Gustave Roussy Cancer Campus, Villejuif, France. · Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Inserm, CNRS, France. · Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Pubmed 29229601
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Cell, Developmental and Cell Biology, Oregon Health and Sciences University, Portland, OR 97239, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Centre de Recherche de Jouy-en-Josas, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas, France. · Centre d'Investigation Clinique Biothérapie, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 29097493
  • INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France. · Division of Molecular Immunology, The Walter and Eliza Hall Institute of Medical Research, 3052, Parkville, Victoria, Australia. · INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France. · Faculté de Médecine - Université Paris-Saclay, Kremlin Bicêtre, 94276, France. · CIC Biotherapie IGR Curie, CIC1428, Gustave Roussy Cancer Campus, Villejuif, 94805, France. · Pubmed 30050125
2017
  • INSERM UMRS1160, Institut Universitaire d'Hématologie, Paris, France. · INSERM-CIC Institut Gustave Roussy, Villejuif, France. · Aix Marseille Université, CNRS, INSERM, CIML, Marseille, France. · Assistance Publique-Hôpitaux de Marseille, Hôpital de la Conception, Service d'Immunologie, Marseille, France. · INSERM U932, Institut Curie, Paris, France. · UMR 892-CRCNA, Institut de Recherche Thérapeutique de l'Université de Nantes, Nantes, France. · Institut Roche, Boulogne-Billancourt, France. · Service de Biochimie et Génétique Moléculaire, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France. · Dermatology department, Hôpital Cochin, Paris, France. · INSERM UMRS1160, Institut Universitaire d'Hématologie, Paris, France. · Pubmed 28576831
2016
  • INSERMU1160, Institut Universitaire d'Hématologie, Hôpital Saint Louis , Paris, France. · Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne , Lausanne, Switzerland. · U1015 INSERM-CIC, Institut Gustave Roussy , Villejuif, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France; University of Paris Sud XI, Kremlin Bicêtre, France. · Inserm U1173 and University of Versailles Saint-Quentin, Montigny-le-Bretonneux, France; APHP, Ambroise Paré Hospital, Division of Genetics, Boulogne-Billancourt, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes , Paris, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes, Paris, France; Université Pierre et Marie Curie, Paris, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France; University of Paris Sud XI, Kremlin Bicêtre, France; Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), Villejuif, France; INSERM, U1015, GRCC, Villejuif, France; Center of Clinical Investigations in Biotherapies of Cancer, CICBT507, GRCC, Villejuif, France. · Pubmed 28123867
  • Department of Medical Oncology, Georges François Leclerc Center, Dijon, France; Institut National de la Santé et de la Recherche Médicale, Avenir Team INSERM, University of Burgundy, Dijon, France; Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Institut Gustave Roussy, Villejuif, France. · Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; INSERM, U1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; University of Paris Sud XI, Villejuif, France. · Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus , Villejuif, France. · Department of Medical Oncology, Georges François Leclerc Center, Dijon, France; Institut National de la Santé et de la Recherche Médicale, Avenir Team INSERM, University of Burgundy, Dijon, France. · Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Institut Gustave Roussy , Villejuif, France. · Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; INSERM, U1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Department of Pathology, University of Virginia, Charlottesville, VA, USA; Department of Surgery, University of Virginia, Charlottesville, VA, USA. · Department of Surgery, University of Virginia , Charlottesville, VA, USA. · Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Institut Gustave Roussy, Villejuif, France; University of Paris Sud XI, Villejuif, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France. · Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; INSERM, U1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden. · Pubmed 27471635
  • Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Institut National de la Santé et de la Recherche Médicale, U1138, Paris, France; Université Pierre et Marie Curie, Paris, France. · Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Villejuif, France; Institut Gustave Roussy Cancer Campus, Villejuif, France; Faculty of Medicine, University of Paris Sud, Kremlin-Bicêtre, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Institut National de la Santé et de la Recherche Médicale, U1138, Paris, France; Université Pierre et Marie Curie, Paris, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Pubmed 27057431
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
  • Inserm U1015, Gustave Roussy Cancer Campus, 114, rue Edouard Vaillant, 94800 Villejuif, France. · Metabolomics and cell biology platforms, Gustave Roussy Cancer Campus, 94800 Villejuif, France. · Centre Hospitalier Lyon Sud, Cancer Research Center of Lyon et Université Claude Bernard Lyon 1, Lyon, France. · Pubmed 27615171
2015
  • Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, Germany. Electronic address: · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy. · Gustave Roussy Cancer Campus, Villejuif, France; INSERM U1015, Villejuif, France; Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25965363
  • INSERMU1160, Institut Universitaire d'Hématologie, Hôpital Saint Louis, 1 Avenue Claude Vellefaux, 75010, Paris, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France. · Centre de Recherche des Cordeliers, 15, rue de l'école de Médecine, 75006, Paris, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes, Paris, France. · Biopathology Department, Institut Curie, Rue d'Ulm, Paris, France. · APHP, Department of Dermatology and Department of Pathology, Hospital Bichat, University Paris Diderot, Hospital Bichat, 75018, Paris, France. · APHP, Department of Pathology, Hospital Cochin, University Paris Descartes, Paris, France. · Pubmed 26218530
  • Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. · Institut National de la Recherche Agronomique (INRA), Micalis-UMR1319, 78360 Jouy-en-Josas, France. · University of Lille, CNRS, INSERM, Centre Hospitalier Régional Universitaire de Lille, Institut Pasteur de Lille, U1019, UMR 8204, Centre d'Infection et d'Immunité de Lille (CIIL), F-59000 Lille, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Department of Radiation Oncology, New York University, New York, NY, USA. · Microenvironment and Immunity Unit, Institut Pasteur, Paris, France. · Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. · Department of Genetics and Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. · Animalerie Centrale, Institut Pasteur, Paris, France. · Centre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale (IPBS), Toulouse, France. Université de Toulouse, Université Paul Sabatier, IPBS, F-31077 Toulouse, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Service de microbiologie, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Laboratory of Immunomonitoring in Oncology, UMS 3655 CNRS/US 23 INSERM, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. INSERM U981, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. INSERM U848, Villejuif, France. Equipe 11 Labellisée-Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, INSERM U1138, Paris, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France. · Unité des Rickettsies, Faculté de Médecine, Université de la Méditerranée, Marseille, France. · Institut Pasteur, Unit of Biology and Genetics of the Bacterial Cell Wall, Paris, France. INSERM, Equipe Avenir, Paris, France. · University of Paris Sud XI, Kremlin-Bicêtre, France. Gastroenterology Department, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Paris, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Pubmed 26541610
  • Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. · Institut National de la Santé et de la Recherche Médicale, Paris, France. · Université Pierre et Marie Curie, Paris, France. · Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France. · Institut National de la Santé et de la Recherche Médicale, Equipe labellisée Ligue Nationale Contre le Cancer, Villejuif, France. · Institut Gustave Roussy Cancer Campus, Villejuif, France. · Faculty of Medicine, University of Paris Sud, Kremlin-Bicêtre, France. · Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France. · Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Pubmed 26059437
  • 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] INSERM, Unité Mixte de Recherche_S959, I, Paris, France [2] Assistance-Publique Hopitaux de Paris, Hôpital Pitié-Salpêtrière, Biotherapy, Paris, France. · INSERM U753, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] Department of Medical Oncology, IGR, Villejuif, France. · Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA. · University of California Los Angeles, Los Angeles, CA, USA. · Ludwig Center for Cancer Immunotherapy, Department of Immunology, and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland [2] Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland. · Department of Dermatology, University Hospital Essen, Germany. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Bristol-Myers Squibb, Redwood City, CA, USA. · Earle A Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · 1] QIMR Berghofer Medical Research Institute, Herston, 4006, Queensland, Australia [2] School of Medicine, The University of Queensland, Herston, QLD 4006, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Department of Medical Oncology, IGR, Villejuif, France [4] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France [4] Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, INSERM U 1138, Paris, France [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France [6] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France [4] Department of Medical Oncology, IGR, Villejuif, France. · Pubmed 25582080
2014
  • Gustave Roussy Cancer Campus; Grand Paris; Villejuif, France. · Pubmed 24719793
  • Laboratorio de Pesquisa em Células Inflamatórias e Neoplásicas Group, Universidade Federal do Paraná, Curitiba, Paraná, Brazil. Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM U1015, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. · Signal Transduction Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Bone Marrow Transplant Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Department of Immunology, Juntendo University School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM U1015, Villejuif, France. Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France. Department of Medical Oncology, IGR, Villejuif, France. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Pubmed 25351955
2018
  • Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia. · Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia. · Gustave Roussy Comprehensive Cancer Institute, Villejuif, France. · INSERM U1015, Villejuif, France. · Faculty of Medicine, Paris Sud/Paris XI University, LeKremlin-Bicêtre, France. · Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. · Pubmed 30420855
2017
  • Gustave Roussy, Université Paris-Saclay, INSERM U1015, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, Metabolomics and Cell Biology Platforms, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, CIC Biothérapie IGR Curie CIC 1428, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, Villejuif, F-94805, France. · Pubmed 28919986
2016
  • INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; Center of Clinical Investigation, Hôpital Necker Enfants Malades, Paris, France. · Saint Antoine Hospital, INSERM ERL 1157-CNRS UMR 7203, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France. · Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA. · Cancer Immunology Branch, Division of Cancer Biology, National Cancer Center, Ilsan, Goyang, Gyeonggi, Korea; Section of Clinical Immunology, Allergy, and Rheumatology, Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA. · Department of Medical Oncology, University Hospital of Besancon, Besancon, France; Clinical Investigational Centre, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM U1098, University of Franche-Comté, Besançon, France. · Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Université de Franche Comté, Service de Dermatologie, Centre Hospitalier Universitaire (CHU), Besançon, France. · Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon and University Claude Bernard Lyon 1, Lyon, France. · Division of Oncology, Department of Medicine, Stanford University, Stanford, California, USA. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France; INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France; Department of Surgery, Gustave Roussy Cancer Center, Villejuif, France; Department of Dermatology, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. Electronic address: · Pubmed 26829031
2014
  • Authors' Affiliations: Cancer Institute Gustave Roussy; Departments of Epidemiology and Statistics and Dermatology; Stabilité génétique et oncogenèse UMR 8200; Clinical Oncology, Melanoma Branch, Cancer Institute Gustave Roussy; Department of BioPathology, Translational Research Laboratory and Biobank, Institute Gustave Roussy; Institut National de la Santé et de la Recherche Medicale (INSERM), U1015; Center of Clinical Investigations CBT507, Biotherapy, Villejuif; INSERM U1102, Institut de Cancérologie de l'Ouest, Saint Herblain; INSERM, U892, Institut de Recherche Thérapeutique, Nantes; INSERM, U1016, Saint Vincent de Paul Hospital; INSERM U1016, CNRS UMR8104, Cochin Institute; Faculté Paris Sud-Université Paris XI, Paris, France; and IRCCS San Matteo University Hospital Foundation, Pavia, Italy. · Pubmed 24197135
  • Authors' Affiliations: INSERM U1016, CNRS UMR 8104, Institut Cochin; APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes; APHP, Department of Dermatology; APHP, Department of Surgery, Hospital Bichat, University Paris Diderot; Surgery Department, Institut Curie, rue d'Ulm-Paris; Hospital Foch, Suresnes; Centre de Recherche des Cordeliers, 15 rue de l'école de médecine; and INSERM U1015 INSERM, Institut Gustave Roussy, Villejuif, Paris, France. · Pubmed 24225017
2013
  • Institut Gustave Roussy, F-94805 Villejuif, France. · Pubmed 23890942
  • Institut de Cancérologie Gustave Roussy; Villejuif, France ; Centre d'Investigation Clinique Biothérapie CICBT 507; Institut de Cancérologie Gustave Roussy; Villejuif, France ; Unité de Thérapie Cellulaire; Institut de Cancérologie Gustave Roussy; Villejuif, France ; Institut National de la Santé et de la Recherche Médicale; U1015; Institut de Cancérologie Gustave Roussy; Villejuif, France. · Pubmed 23525357
  • Dermatology Unit, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Pubmed 23439861
2011
  • Institut Gustave Roussy, Université Paris Descartes, Paris, France. · Pubmed 21724589
2010
Probable:    INSERM France      
2019
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands. · Department of Immuno-Oncology, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Pathology, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Biostatistics, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Department of Medicine, Service of Dermatology Gustave Roussy and University Paris-Sud. · INSERM U 1015, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · University Paris-Sud, Le Kremlin Bicetre, France. · Pubmed 31646109
2018
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Department of Microbiology and Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France. · Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, and Department of Pharmacology, University of California San Diego, La Jolla, California. · Immunology and Virology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia, Crawley, Western Australia, Australia. · University Paris-Saclay, Kremlin Bicêtre, France. · CIC1428, Gustave Roussy Cancer Campus, Villejuif, France. · Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Inserm, CNRS, France. · Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Pubmed 29229601
  • INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France. · Division of Molecular Immunology, The Walter and Eliza Hall Institute of Medical Research, 3052, Parkville, Victoria, Australia. · INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France. · Faculté de Médecine - Université Paris-Saclay, Kremlin Bicêtre, 94276, France. · CIC Biotherapie IGR Curie, CIC1428, Gustave Roussy Cancer Campus, Villejuif, 94805, France. · Pubmed 30050125
2017
  • INSERM UMRS1160, Institut Universitaire d'Hématologie, Paris, France. · INSERM-CIC Institut Gustave Roussy, Villejuif, France. · Aix Marseille Université, CNRS, INSERM, CIML, Marseille, France. · Assistance Publique-Hôpitaux de Marseille, Hôpital de la Conception, Service d'Immunologie, Marseille, France. · INSERM U932, Institut Curie, Paris, France. · UMR 892-CRCNA, Institut de Recherche Thérapeutique de l'Université de Nantes, Nantes, France. · Institut Roche, Boulogne-Billancourt, France. · Service de Biochimie et Génétique Moléculaire, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France. · Dermatology department, Hôpital Cochin, Paris, France. · INSERM UMRS1160, Institut Universitaire d'Hématologie, Paris, France. · Pubmed 28576831
2016
  • INSERMU1160, Institut Universitaire d'Hématologie, Hôpital Saint Louis , Paris, France. · Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne , Lausanne, Switzerland. · U1015 INSERM-CIC, Institut Gustave Roussy , Villejuif, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France; University of Paris Sud XI, Kremlin Bicêtre, France. · Inserm U1173 and University of Versailles Saint-Quentin, Montigny-le-Bretonneux, France; APHP, Ambroise Paré Hospital, Division of Genetics, Boulogne-Billancourt, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes , Paris, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes, Paris, France; Université Pierre et Marie Curie, Paris, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France; University of Paris Sud XI, Kremlin Bicêtre, France; Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), Villejuif, France; INSERM, U1015, GRCC, Villejuif, France; Center of Clinical Investigations in Biotherapies of Cancer, CICBT507, GRCC, Villejuif, France. · Pubmed 28123867
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
  • Inserm U1015, Gustave Roussy Cancer Campus, 114, rue Edouard Vaillant, 94800 Villejuif, France. · Metabolomics and cell biology platforms, Gustave Roussy Cancer Campus, 94800 Villejuif, France. · Centre Hospitalier Lyon Sud, Cancer Research Center of Lyon et Université Claude Bernard Lyon 1, Lyon, France. · Pubmed 27615171
2015
  • Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, Germany. Electronic address: · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy. · Gustave Roussy Cancer Campus, Villejuif, France; INSERM U1015, Villejuif, France; Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25965363
  • INSERMU1160, Institut Universitaire d'Hématologie, Hôpital Saint Louis, 1 Avenue Claude Vellefaux, 75010, Paris, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France. · Centre de Recherche des Cordeliers, 15, rue de l'école de Médecine, 75006, Paris, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes, Paris, France. · Biopathology Department, Institut Curie, Rue d'Ulm, Paris, France. · APHP, Department of Dermatology and Department of Pathology, Hospital Bichat, University Paris Diderot, Hospital Bichat, 75018, Paris, France. · APHP, Department of Pathology, Hospital Cochin, University Paris Descartes, Paris, France. · Pubmed 26218530
  • Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. · Institut National de la Recherche Agronomique (INRA), Micalis-UMR1319, 78360 Jouy-en-Josas, France. · University of Lille, CNRS, INSERM, Centre Hospitalier Régional Universitaire de Lille, Institut Pasteur de Lille, U1019, UMR 8204, Centre d'Infection et d'Immunité de Lille (CIIL), F-59000 Lille, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Department of Radiation Oncology, New York University, New York, NY, USA. · Microenvironment and Immunity Unit, Institut Pasteur, Paris, France. · Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. · Department of Genetics and Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. · Animalerie Centrale, Institut Pasteur, Paris, France. · Centre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale (IPBS), Toulouse, France. Université de Toulouse, Université Paul Sabatier, IPBS, F-31077 Toulouse, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Service de microbiologie, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Laboratory of Immunomonitoring in Oncology, UMS 3655 CNRS/US 23 INSERM, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. INSERM U981, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. INSERM U848, Villejuif, France. Equipe 11 Labellisée-Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, INSERM U1138, Paris, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France. · Unité des Rickettsies, Faculté de Médecine, Université de la Méditerranée, Marseille, France. · Institut Pasteur, Unit of Biology and Genetics of the Bacterial Cell Wall, Paris, France. INSERM, Equipe Avenir, Paris, France. · University of Paris Sud XI, Kremlin-Bicêtre, France. Gastroenterology Department, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Paris, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Pubmed 26541610
  • 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] INSERM, Unité Mixte de Recherche_S959, I, Paris, France [2] Assistance-Publique Hopitaux de Paris, Hôpital Pitié-Salpêtrière, Biotherapy, Paris, France. · INSERM U753, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] Department of Medical Oncology, IGR, Villejuif, France. · Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA. · University of California Los Angeles, Los Angeles, CA, USA. · Ludwig Center for Cancer Immunotherapy, Department of Immunology, and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland [2] Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland. · Department of Dermatology, University Hospital Essen, Germany. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Bristol-Myers Squibb, Redwood City, CA, USA. · Earle A Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · 1] QIMR Berghofer Medical Research Institute, Herston, 4006, Queensland, Australia [2] School of Medicine, The University of Queensland, Herston, QLD 4006, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Department of Medical Oncology, IGR, Villejuif, France [4] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France [4] Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, INSERM U 1138, Paris, France [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France [6] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France [4] Department of Medical Oncology, IGR, Villejuif, France. · Pubmed 25582080
2014
  • Laboratorio de Pesquisa em Células Inflamatórias e Neoplásicas Group, Universidade Federal do Paraná, Curitiba, Paraná, Brazil. Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM U1015, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. · Signal Transduction Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Bone Marrow Transplant Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Department of Immunology, Juntendo University School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM U1015, Villejuif, France. Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France. Department of Medical Oncology, IGR, Villejuif, France. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Pubmed 25351955
2018
  • Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia. · Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia. · Gustave Roussy Comprehensive Cancer Institute, Villejuif, France. · INSERM U1015, Villejuif, France. · Faculty of Medicine, Paris Sud/Paris XI University, LeKremlin-Bicêtre, France. · Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. · Pubmed 30420855
2017
  • Gustave Roussy, Université Paris-Saclay, INSERM U1015, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, Metabolomics and Cell Biology Platforms, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, CIC Biothérapie IGR Curie CIC 1428, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, Villejuif, F-94805, France. · Pubmed 28919986
2016
  • INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; Center of Clinical Investigation, Hôpital Necker Enfants Malades, Paris, France. · Saint Antoine Hospital, INSERM ERL 1157-CNRS UMR 7203, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France. · Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA. · Cancer Immunology Branch, Division of Cancer Biology, National Cancer Center, Ilsan, Goyang, Gyeonggi, Korea; Section of Clinical Immunology, Allergy, and Rheumatology, Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA. · Department of Medical Oncology, University Hospital of Besancon, Besancon, France; Clinical Investigational Centre, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM U1098, University of Franche-Comté, Besançon, France. · Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Université de Franche Comté, Service de Dermatologie, Centre Hospitalier Universitaire (CHU), Besançon, France. · Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon and University Claude Bernard Lyon 1, Lyon, France. · Division of Oncology, Department of Medicine, Stanford University, Stanford, California, USA. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France; INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France; Department of Surgery, Gustave Roussy Cancer Center, Villejuif, France; Department of Dermatology, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. Electronic address: · Pubmed 26829031
2014
  • Authors' Affiliations: Cancer Institute Gustave Roussy; Departments of Epidemiology and Statistics and Dermatology; Stabilité génétique et oncogenèse UMR 8200; Clinical Oncology, Melanoma Branch, Cancer Institute Gustave Roussy; Department of BioPathology, Translational Research Laboratory and Biobank, Institute Gustave Roussy; Institut National de la Santé et de la Recherche Medicale (INSERM), U1015; Center of Clinical Investigations CBT507, Biotherapy, Villejuif; INSERM U1102, Institut de Cancérologie de l'Ouest, Saint Herblain; INSERM, U892, Institut de Recherche Thérapeutique, Nantes; INSERM, U1016, Saint Vincent de Paul Hospital; INSERM U1016, CNRS UMR8104, Cochin Institute; Faculté Paris Sud-Université Paris XI, Paris, France; and IRCCS San Matteo University Hospital Foundation, Pavia, Italy. · Pubmed 24197135
  • Authors' Affiliations: INSERM U1016, CNRS UMR 8104, Institut Cochin; APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes; APHP, Department of Dermatology; APHP, Department of Surgery, Hospital Bichat, University Paris Diderot; Surgery Department, Institut Curie, rue d'Ulm-Paris; Hospital Foch, Suresnes; Centre de Recherche des Cordeliers, 15 rue de l'école de médecine; and INSERM U1015 INSERM, Institut Gustave Roussy, Villejuif, Paris, France. · Pubmed 24225017
2011
  • Inserm U986, Diabetes & Autoimmunity Research Laboratory, Paris, France. · Pubmed 21715316
Probable:    Universite Paris-Saclay      
2018
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Department of Microbiology and Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France. · Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, and Department of Pharmacology, University of California San Diego, La Jolla, California. · Immunology and Virology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia, Crawley, Western Australia, Australia. · University Paris-Saclay, Kremlin Bicêtre, France. · CIC1428, Gustave Roussy Cancer Campus, Villejuif, France. · Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Inserm, CNRS, France. · Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Pubmed 29229601
  • INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France. · Division of Molecular Immunology, The Walter and Eliza Hall Institute of Medical Research, 3052, Parkville, Victoria, Australia. · INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France. · Faculté de Médecine - Université Paris-Saclay, Kremlin Bicêtre, 94276, France. · CIC Biotherapie IGR Curie, CIC1428, Gustave Roussy Cancer Campus, Villejuif, 94805, France. · Pubmed 30050125
2017
  • Gustave Roussy, Université Paris-Saclay, INSERM U1015, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, Metabolomics and Cell Biology Platforms, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, CIC Biothérapie IGR Curie CIC 1428, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, Villejuif, F-94805, France. · Pubmed 28919986
2016
  • INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; Center of Clinical Investigation, Hôpital Necker Enfants Malades, Paris, France. · Saint Antoine Hospital, INSERM ERL 1157-CNRS UMR 7203, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France. · Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA. · Cancer Immunology Branch, Division of Cancer Biology, National Cancer Center, Ilsan, Goyang, Gyeonggi, Korea; Section of Clinical Immunology, Allergy, and Rheumatology, Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA. · Department of Medical Oncology, University Hospital of Besancon, Besancon, France; Clinical Investigational Centre, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM U1098, University of Franche-Comté, Besançon, France. · Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Université de Franche Comté, Service de Dermatologie, Centre Hospitalier Universitaire (CHU), Besançon, France. · Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon and University Claude Bernard Lyon 1, Lyon, France. · Division of Oncology, Department of Medicine, Stanford University, Stanford, California, USA. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France; INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France; Department of Surgery, Gustave Roussy Cancer Center, Villejuif, France; Department of Dermatology, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. Electronic address: · Pubmed 26829031
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 32 total) written by Laurence Zitvogel about Melanoma:

  • Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas. 2019
  • Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy). 2019
  • Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers. 2018
  • A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment. 2018
  • Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. 2018
  • Reply to 'Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma'. 2018
  • Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma. 2017
  • Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on 2017
  • NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution. 2016
  • Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate. 2016
Show List of Full Article Records
Google Searches

Learn more about Laurence Zitvogel using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Institut Gustave Roussy
INSERM France
Universite Paris-Saclay
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Institut Gustave Roussy
2019
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands. · Department of Immuno-Oncology, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Pathology, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Biostatistics, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Department of Medicine, Service of Dermatology Gustave Roussy and University Paris-Sud. · INSERM U 1015, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · University Paris-Sud, Le Kremlin Bicetre, France. · Pubmed 31646109
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Medical Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Experimental Pharmacology Unit, Department of Translational Research, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA. · Department of Pathology and Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · The Angeles Clinic, Experimental Therapeutics Cedars Sinai Foundation, Los Angeles, CA, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · University of Chicago Medical Center, Chicago, IL, USA. · Oncology Department, UNIL-CHUV, Lausanne, Switzerland. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Institut de Cancérologie, Gustave Roussy Cancer Campus, Villejuif, Paris, France. · Refuge Biotechnologies, Menlo Park, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, 9609 Medical Center Drive, Bethesda, MD, 20892-7420, USA. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Pubmed 31331337
2018
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Department of Microbiology and Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France. · Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, and Department of Pharmacology, University of California San Diego, La Jolla, California. · Immunology and Virology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia, Crawley, Western Australia, Australia. · University Paris-Saclay, Kremlin Bicêtre, France. · CIC1428, Gustave Roussy Cancer Campus, Villejuif, France. · Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Inserm, CNRS, France. · Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Pubmed 29229601
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Cell, Developmental and Cell Biology, Oregon Health and Sciences University, Portland, OR 97239, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Centre de Recherche de Jouy-en-Josas, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas, France. · Centre d'Investigation Clinique Biothérapie, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 29097493
  • INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France. · Division of Molecular Immunology, The Walter and Eliza Hall Institute of Medical Research, 3052, Parkville, Victoria, Australia. · INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France. · Faculté de Médecine - Université Paris-Saclay, Kremlin Bicêtre, 94276, France. · CIC Biotherapie IGR Curie, CIC1428, Gustave Roussy Cancer Campus, Villejuif, 94805, France. · Pubmed 30050125
2017
  • INSERM UMRS1160, Institut Universitaire d'Hématologie, Paris, France. · INSERM-CIC Institut Gustave Roussy, Villejuif, France. · Aix Marseille Université, CNRS, INSERM, CIML, Marseille, France. · Assistance Publique-Hôpitaux de Marseille, Hôpital de la Conception, Service d'Immunologie, Marseille, France. · INSERM U932, Institut Curie, Paris, France. · UMR 892-CRCNA, Institut de Recherche Thérapeutique de l'Université de Nantes, Nantes, France. · Institut Roche, Boulogne-Billancourt, France. · Service de Biochimie et Génétique Moléculaire, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France. · Dermatology department, Hôpital Cochin, Paris, France. · INSERM UMRS1160, Institut Universitaire d'Hématologie, Paris, France. · Pubmed 28576831
2016
  • INSERMU1160, Institut Universitaire d'Hématologie, Hôpital Saint Louis , Paris, France. · Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne , Lausanne, Switzerland. · U1015 INSERM-CIC, Institut Gustave Roussy , Villejuif, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France; University of Paris Sud XI, Kremlin Bicêtre, France. · Inserm U1173 and University of Versailles Saint-Quentin, Montigny-le-Bretonneux, France; APHP, Ambroise Paré Hospital, Division of Genetics, Boulogne-Billancourt, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes , Paris, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes, Paris, France; Université Pierre et Marie Curie, Paris, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France; University of Paris Sud XI, Kremlin Bicêtre, France; Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), Villejuif, France; INSERM, U1015, GRCC, Villejuif, France; Center of Clinical Investigations in Biotherapies of Cancer, CICBT507, GRCC, Villejuif, France. · Pubmed 28123867
  • Department of Medical Oncology, Georges François Leclerc Center, Dijon, France; Institut National de la Santé et de la Recherche Médicale, Avenir Team INSERM, University of Burgundy, Dijon, France; Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Institut Gustave Roussy, Villejuif, France. · Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; INSERM, U1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; University of Paris Sud XI, Villejuif, France. · Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus , Villejuif, France. · Department of Medical Oncology, Georges François Leclerc Center, Dijon, France; Institut National de la Santé et de la Recherche Médicale, Avenir Team INSERM, University of Burgundy, Dijon, France. · Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Institut Gustave Roussy , Villejuif, France. · Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; INSERM, U1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Department of Pathology, University of Virginia, Charlottesville, VA, USA; Department of Surgery, University of Virginia, Charlottesville, VA, USA. · Department of Surgery, University of Virginia , Charlottesville, VA, USA. · Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Institut Gustave Roussy, Villejuif, France; University of Paris Sud XI, Villejuif, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France. · Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; INSERM, U1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden. · Pubmed 27471635
  • Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Institut National de la Santé et de la Recherche Médicale, U1138, Paris, France; Université Pierre et Marie Curie, Paris, France. · Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Villejuif, France; Institut Gustave Roussy Cancer Campus, Villejuif, France; Faculty of Medicine, University of Paris Sud, Kremlin-Bicêtre, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Institut National de la Santé et de la Recherche Médicale, U1138, Paris, France; Université Pierre et Marie Curie, Paris, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Pubmed 27057431
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
  • Inserm U1015, Gustave Roussy Cancer Campus, 114, rue Edouard Vaillant, 94800 Villejuif, France. · Metabolomics and cell biology platforms, Gustave Roussy Cancer Campus, 94800 Villejuif, France. · Centre Hospitalier Lyon Sud, Cancer Research Center of Lyon et Université Claude Bernard Lyon 1, Lyon, France. · Pubmed 27615171
2015
  • Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, Germany. Electronic address: · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy. · Gustave Roussy Cancer Campus, Villejuif, France; INSERM U1015, Villejuif, France; Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25965363
  • INSERMU1160, Institut Universitaire d'Hématologie, Hôpital Saint Louis, 1 Avenue Claude Vellefaux, 75010, Paris, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France. · Centre de Recherche des Cordeliers, 15, rue de l'école de Médecine, 75006, Paris, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes, Paris, France. · Biopathology Department, Institut Curie, Rue d'Ulm, Paris, France. · APHP, Department of Dermatology and Department of Pathology, Hospital Bichat, University Paris Diderot, Hospital Bichat, 75018, Paris, France. · APHP, Department of Pathology, Hospital Cochin, University Paris Descartes, Paris, France. · Pubmed 26218530
  • Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. · Institut National de la Recherche Agronomique (INRA), Micalis-UMR1319, 78360 Jouy-en-Josas, France. · University of Lille, CNRS, INSERM, Centre Hospitalier Régional Universitaire de Lille, Institut Pasteur de Lille, U1019, UMR 8204, Centre d'Infection et d'Immunité de Lille (CIIL), F-59000 Lille, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Department of Radiation Oncology, New York University, New York, NY, USA. · Microenvironment and Immunity Unit, Institut Pasteur, Paris, France. · Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. · Department of Genetics and Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. · Animalerie Centrale, Institut Pasteur, Paris, France. · Centre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale (IPBS), Toulouse, France. Université de Toulouse, Université Paul Sabatier, IPBS, F-31077 Toulouse, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Service de microbiologie, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Laboratory of Immunomonitoring in Oncology, UMS 3655 CNRS/US 23 INSERM, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. INSERM U981, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. INSERM U848, Villejuif, France. Equipe 11 Labellisée-Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, INSERM U1138, Paris, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France. · Unité des Rickettsies, Faculté de Médecine, Université de la Méditerranée, Marseille, France. · Institut Pasteur, Unit of Biology and Genetics of the Bacterial Cell Wall, Paris, France. INSERM, Equipe Avenir, Paris, France. · University of Paris Sud XI, Kremlin-Bicêtre, France. Gastroenterology Department, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Paris, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Pubmed 26541610
  • Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. · Institut National de la Santé et de la Recherche Médicale, Paris, France. · Université Pierre et Marie Curie, Paris, France. · Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France. · Institut National de la Santé et de la Recherche Médicale, Equipe labellisée Ligue Nationale Contre le Cancer, Villejuif, France. · Institut Gustave Roussy Cancer Campus, Villejuif, France. · Faculty of Medicine, University of Paris Sud, Kremlin-Bicêtre, France. · Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France. · Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Pubmed 26059437
  • 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] INSERM, Unité Mixte de Recherche_S959, I, Paris, France [2] Assistance-Publique Hopitaux de Paris, Hôpital Pitié-Salpêtrière, Biotherapy, Paris, France. · INSERM U753, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] Department of Medical Oncology, IGR, Villejuif, France. · Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA. · University of California Los Angeles, Los Angeles, CA, USA. · Ludwig Center for Cancer Immunotherapy, Department of Immunology, and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland [2] Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland. · Department of Dermatology, University Hospital Essen, Germany. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Bristol-Myers Squibb, Redwood City, CA, USA. · Earle A Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · 1] QIMR Berghofer Medical Research Institute, Herston, 4006, Queensland, Australia [2] School of Medicine, The University of Queensland, Herston, QLD 4006, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Department of Medical Oncology, IGR, Villejuif, France [4] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France [4] Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, INSERM U 1138, Paris, France [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France [6] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France [4] Department of Medical Oncology, IGR, Villejuif, France. · Pubmed 25582080
2014
  • Gustave Roussy Cancer Campus; Grand Paris; Villejuif, France. · Pubmed 24719793
  • Laboratorio de Pesquisa em Células Inflamatórias e Neoplásicas Group, Universidade Federal do Paraná, Curitiba, Paraná, Brazil. Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM U1015, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. · Signal Transduction Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Bone Marrow Transplant Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Department of Immunology, Juntendo University School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM U1015, Villejuif, France. Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France. Department of Medical Oncology, IGR, Villejuif, France. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Pubmed 25351955
2018
  • Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia. · Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia. · Gustave Roussy Comprehensive Cancer Institute, Villejuif, France. · INSERM U1015, Villejuif, France. · Faculty of Medicine, Paris Sud/Paris XI University, LeKremlin-Bicêtre, France. · Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. · Pubmed 30420855
2017
  • Gustave Roussy, Université Paris-Saclay, INSERM U1015, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, Metabolomics and Cell Biology Platforms, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, CIC Biothérapie IGR Curie CIC 1428, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, Villejuif, F-94805, France. · Pubmed 28919986
2016
  • INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; Center of Clinical Investigation, Hôpital Necker Enfants Malades, Paris, France. · Saint Antoine Hospital, INSERM ERL 1157-CNRS UMR 7203, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France. · Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA. · Cancer Immunology Branch, Division of Cancer Biology, National Cancer Center, Ilsan, Goyang, Gyeonggi, Korea; Section of Clinical Immunology, Allergy, and Rheumatology, Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA. · Department of Medical Oncology, University Hospital of Besancon, Besancon, France; Clinical Investigational Centre, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM U1098, University of Franche-Comté, Besançon, France. · Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Université de Franche Comté, Service de Dermatologie, Centre Hospitalier Universitaire (CHU), Besançon, France. · Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon and University Claude Bernard Lyon 1, Lyon, France. · Division of Oncology, Department of Medicine, Stanford University, Stanford, California, USA. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France; INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France; Department of Surgery, Gustave Roussy Cancer Center, Villejuif, France; Department of Dermatology, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. Electronic address: · Pubmed 26829031
2014
  • Authors' Affiliations: Cancer Institute Gustave Roussy; Departments of Epidemiology and Statistics and Dermatology; Stabilité génétique et oncogenèse UMR 8200; Clinical Oncology, Melanoma Branch, Cancer Institute Gustave Roussy; Department of BioPathology, Translational Research Laboratory and Biobank, Institute Gustave Roussy; Institut National de la Santé et de la Recherche Medicale (INSERM), U1015; Center of Clinical Investigations CBT507, Biotherapy, Villejuif; INSERM U1102, Institut de Cancérologie de l'Ouest, Saint Herblain; INSERM, U892, Institut de Recherche Thérapeutique, Nantes; INSERM, U1016, Saint Vincent de Paul Hospital; INSERM U1016, CNRS UMR8104, Cochin Institute; Faculté Paris Sud-Université Paris XI, Paris, France; and IRCCS San Matteo University Hospital Foundation, Pavia, Italy. · Pubmed 24197135
  • Authors' Affiliations: INSERM U1016, CNRS UMR 8104, Institut Cochin; APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes; APHP, Department of Dermatology; APHP, Department of Surgery, Hospital Bichat, University Paris Diderot; Surgery Department, Institut Curie, rue d'Ulm-Paris; Hospital Foch, Suresnes; Centre de Recherche des Cordeliers, 15 rue de l'école de médecine; and INSERM U1015 INSERM, Institut Gustave Roussy, Villejuif, Paris, France. · Pubmed 24225017
2013
  • Institut Gustave Roussy, F-94805 Villejuif, France. · Pubmed 23890942
  • Institut de Cancérologie Gustave Roussy; Villejuif, France ; Centre d'Investigation Clinique Biothérapie CICBT 507; Institut de Cancérologie Gustave Roussy; Villejuif, France ; Unité de Thérapie Cellulaire; Institut de Cancérologie Gustave Roussy; Villejuif, France ; Institut National de la Santé et de la Recherche Médicale; U1015; Institut de Cancérologie Gustave Roussy; Villejuif, France. · Pubmed 23525357
  • Dermatology Unit, Institut de Cancérologie Gustave Roussy, Villejuif, France. · Pubmed 23439861
2011
  • Institut Gustave Roussy, Université Paris Descartes, Paris, France. · Pubmed 21724589
2010
INSERM France
2019
  • Department of Surgical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands. · Department of Immuno-Oncology, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Pathology, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Biostatistics, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Department of Medicine, Service of Dermatology Gustave Roussy and University Paris-Sud. · INSERM U 1015, Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · University Paris-Sud, Le Kremlin Bicetre, France. · Pubmed 31646109
2018
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Department of Microbiology and Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France. · Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, and Department of Pharmacology, University of California San Diego, La Jolla, California. · Immunology and Virology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia, Crawley, Western Australia, Australia. · University Paris-Saclay, Kremlin Bicêtre, France. · CIC1428, Gustave Roussy Cancer Campus, Villejuif, France. · Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Inserm, CNRS, France. · Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Pubmed 29229601
  • INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France. · Division of Molecular Immunology, The Walter and Eliza Hall Institute of Medical Research, 3052, Parkville, Victoria, Australia. · INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France. · Faculté de Médecine - Université Paris-Saclay, Kremlin Bicêtre, 94276, France. · CIC Biotherapie IGR Curie, CIC1428, Gustave Roussy Cancer Campus, Villejuif, 94805, France. · Pubmed 30050125
2017
  • INSERM UMRS1160, Institut Universitaire d'Hématologie, Paris, France. · INSERM-CIC Institut Gustave Roussy, Villejuif, France. · Aix Marseille Université, CNRS, INSERM, CIML, Marseille, France. · Assistance Publique-Hôpitaux de Marseille, Hôpital de la Conception, Service d'Immunologie, Marseille, France. · INSERM U932, Institut Curie, Paris, France. · UMR 892-CRCNA, Institut de Recherche Thérapeutique de l'Université de Nantes, Nantes, France. · Institut Roche, Boulogne-Billancourt, France. · Service de Biochimie et Génétique Moléculaire, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France. · Dermatology department, Hôpital Cochin, Paris, France. · INSERM UMRS1160, Institut Universitaire d'Hématologie, Paris, France. · Pubmed 28576831
2016
  • INSERMU1160, Institut Universitaire d'Hématologie, Hôpital Saint Louis , Paris, France. · Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne , Lausanne, Switzerland. · U1015 INSERM-CIC, Institut Gustave Roussy , Villejuif, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France; University of Paris Sud XI, Kremlin Bicêtre, France. · Inserm U1173 and University of Versailles Saint-Quentin, Montigny-le-Bretonneux, France; APHP, Ambroise Paré Hospital, Division of Genetics, Boulogne-Billancourt, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes , Paris, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes, Paris, France; Université Pierre et Marie Curie, Paris, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France; University of Paris Sud XI, Kremlin Bicêtre, France; Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), Villejuif, France; INSERM, U1015, GRCC, Villejuif, France; Center of Clinical Investigations in Biotherapies of Cancer, CICBT507, GRCC, Villejuif, France. · Pubmed 28123867
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
  • Inserm U1015, Gustave Roussy Cancer Campus, 114, rue Edouard Vaillant, 94800 Villejuif, France. · Metabolomics and cell biology platforms, Gustave Roussy Cancer Campus, 94800 Villejuif, France. · Centre Hospitalier Lyon Sud, Cancer Research Center of Lyon et Université Claude Bernard Lyon 1, Lyon, France. · Pubmed 27615171
2015
  • Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, Germany. Electronic address: · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy. · Gustave Roussy Cancer Campus, Villejuif, France; INSERM U1015, Villejuif, France; Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25965363
  • INSERMU1160, Institut Universitaire d'Hématologie, Hôpital Saint Louis, 1 Avenue Claude Vellefaux, 75010, Paris, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France. · Centre de Recherche des Cordeliers, 15, rue de l'école de Médecine, 75006, Paris, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes, Paris, France. · Biopathology Department, Institut Curie, Rue d'Ulm, Paris, France. · APHP, Department of Dermatology and Department of Pathology, Hospital Bichat, University Paris Diderot, Hospital Bichat, 75018, Paris, France. · APHP, Department of Pathology, Hospital Cochin, University Paris Descartes, Paris, France. · Pubmed 26218530
  • Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. · Institut National de la Recherche Agronomique (INRA), Micalis-UMR1319, 78360 Jouy-en-Josas, France. · University of Lille, CNRS, INSERM, Centre Hospitalier Régional Universitaire de Lille, Institut Pasteur de Lille, U1019, UMR 8204, Centre d'Infection et d'Immunité de Lille (CIIL), F-59000 Lille, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Department of Radiation Oncology, New York University, New York, NY, USA. · Microenvironment and Immunity Unit, Institut Pasteur, Paris, France. · Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. · Department of Genetics and Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. · Animalerie Centrale, Institut Pasteur, Paris, France. · Centre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale (IPBS), Toulouse, France. Université de Toulouse, Université Paul Sabatier, IPBS, F-31077 Toulouse, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Service de microbiologie, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Laboratory of Immunomonitoring in Oncology, UMS 3655 CNRS/US 23 INSERM, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. INSERM U981, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. INSERM U848, Villejuif, France. Equipe 11 Labellisée-Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, INSERM U1138, Paris, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France. · Unité des Rickettsies, Faculté de Médecine, Université de la Méditerranée, Marseille, France. · Institut Pasteur, Unit of Biology and Genetics of the Bacterial Cell Wall, Paris, France. INSERM, Equipe Avenir, Paris, France. · University of Paris Sud XI, Kremlin-Bicêtre, France. Gastroenterology Department, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Paris, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Pubmed 26541610
  • 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] INSERM, Unité Mixte de Recherche_S959, I, Paris, France [2] Assistance-Publique Hopitaux de Paris, Hôpital Pitié-Salpêtrière, Biotherapy, Paris, France. · INSERM U753, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] Department of Medical Oncology, IGR, Villejuif, France. · Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA. · University of California Los Angeles, Los Angeles, CA, USA. · Ludwig Center for Cancer Immunotherapy, Department of Immunology, and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland [2] Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland. · Department of Dermatology, University Hospital Essen, Germany. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Bristol-Myers Squibb, Redwood City, CA, USA. · Earle A Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · 1] QIMR Berghofer Medical Research Institute, Herston, 4006, Queensland, Australia [2] School of Medicine, The University of Queensland, Herston, QLD 4006, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Department of Medical Oncology, IGR, Villejuif, France [4] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France [4] Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, INSERM U 1138, Paris, France [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France [6] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France [4] Department of Medical Oncology, IGR, Villejuif, France. · Pubmed 25582080
2014
  • Laboratorio de Pesquisa em Células Inflamatórias e Neoplásicas Group, Universidade Federal do Paraná, Curitiba, Paraná, Brazil. Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM U1015, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. · Signal Transduction Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Bone Marrow Transplant Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Department of Immunology, Juntendo University School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM U1015, Villejuif, France. Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France. Department of Medical Oncology, IGR, Villejuif, France. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Pubmed 25351955
2018
  • Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia. · Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia. · Gustave Roussy Comprehensive Cancer Institute, Villejuif, France. · INSERM U1015, Villejuif, France. · Faculty of Medicine, Paris Sud/Paris XI University, LeKremlin-Bicêtre, France. · Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. · Pubmed 30420855
2017
  • Gustave Roussy, Université Paris-Saclay, INSERM U1015, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, Metabolomics and Cell Biology Platforms, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, CIC Biothérapie IGR Curie CIC 1428, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, Villejuif, F-94805, France. · Pubmed 28919986
2016
  • INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; Center of Clinical Investigation, Hôpital Necker Enfants Malades, Paris, France. · Saint Antoine Hospital, INSERM ERL 1157-CNRS UMR 7203, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France. · Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA. · Cancer Immunology Branch, Division of Cancer Biology, National Cancer Center, Ilsan, Goyang, Gyeonggi, Korea; Section of Clinical Immunology, Allergy, and Rheumatology, Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA. · Department of Medical Oncology, University Hospital of Besancon, Besancon, France; Clinical Investigational Centre, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM U1098, University of Franche-Comté, Besançon, France. · Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Université de Franche Comté, Service de Dermatologie, Centre Hospitalier Universitaire (CHU), Besançon, France. · Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon and University Claude Bernard Lyon 1, Lyon, France. · Division of Oncology, Department of Medicine, Stanford University, Stanford, California, USA. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France; INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France; Department of Surgery, Gustave Roussy Cancer Center, Villejuif, France; Department of Dermatology, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. Electronic address: · Pubmed 26829031
2014
  • Authors' Affiliations: Cancer Institute Gustave Roussy; Departments of Epidemiology and Statistics and Dermatology; Stabilité génétique et oncogenèse UMR 8200; Clinical Oncology, Melanoma Branch, Cancer Institute Gustave Roussy; Department of BioPathology, Translational Research Laboratory and Biobank, Institute Gustave Roussy; Institut National de la Santé et de la Recherche Medicale (INSERM), U1015; Center of Clinical Investigations CBT507, Biotherapy, Villejuif; INSERM U1102, Institut de Cancérologie de l'Ouest, Saint Herblain; INSERM, U892, Institut de Recherche Thérapeutique, Nantes; INSERM, U1016, Saint Vincent de Paul Hospital; INSERM U1016, CNRS UMR8104, Cochin Institute; Faculté Paris Sud-Université Paris XI, Paris, France; and IRCCS San Matteo University Hospital Foundation, Pavia, Italy. · Pubmed 24197135
  • Authors' Affiliations: INSERM U1016, CNRS UMR 8104, Institut Cochin; APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes; APHP, Department of Dermatology; APHP, Department of Surgery, Hospital Bichat, University Paris Diderot; Surgery Department, Institut Curie, rue d'Ulm-Paris; Hospital Foch, Suresnes; Centre de Recherche des Cordeliers, 15 rue de l'école de médecine; and INSERM U1015 INSERM, Institut Gustave Roussy, Villejuif, Paris, France. · Pubmed 24225017
2011
  • Inserm U986, Diabetes & Autoimmunity Research Laboratory, Paris, France. · Pubmed 21715316
Universite Paris-Saclay
2018
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Department of Microbiology and Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France. · Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, and Department of Pharmacology, University of California San Diego, La Jolla, California. · Immunology and Virology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia, Crawley, Western Australia, Australia. · University Paris-Saclay, Kremlin Bicêtre, France. · CIC1428, Gustave Roussy Cancer Campus, Villejuif, France. · Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Inserm, CNRS, France. · Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Pubmed 29229601
  • INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France. · Division of Molecular Immunology, The Walter and Eliza Hall Institute of Medical Research, 3052, Parkville, Victoria, Australia. · INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France. · Faculté de Médecine - Université Paris-Saclay, Kremlin Bicêtre, 94276, France. · CIC Biotherapie IGR Curie, CIC1428, Gustave Roussy Cancer Campus, Villejuif, 94805, France. · Pubmed 30050125
2017
  • Gustave Roussy, Université Paris-Saclay, INSERM U1015, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, Metabolomics and Cell Biology Platforms, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, CIC Biothérapie IGR Curie CIC 1428, Villejuif, F-94805, France. · Gustave Roussy, Université Paris-saclay, Villejuif, F-94805, France. · Pubmed 28919986
2016
  • INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; Gustave Roussy Cancer Center, Villejuif, France; Center of Clinical Investigation, Hôpital Necker Enfants Malades, Paris, France. · Saint Antoine Hospital, INSERM ERL 1157-CNRS UMR 7203, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France. · Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA. · Cancer Immunology Branch, Division of Cancer Biology, National Cancer Center, Ilsan, Goyang, Gyeonggi, Korea; Section of Clinical Immunology, Allergy, and Rheumatology, Department of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA. · Department of Medical Oncology, University Hospital of Besancon, Besancon, France; Clinical Investigational Centre, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM U1098, University of Franche-Comté, Besançon, France. · Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany. · Université de Franche Comté, Service de Dermatologie, Centre Hospitalier Universitaire (CHU), Besançon, France. · Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon and University Claude Bernard Lyon 1, Lyon, France. · Division of Oncology, Department of Medicine, Stanford University, Stanford, California, USA. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. · Gustave Roussy Cancer Center, Villejuif, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France; INSERM U1138, Centre de Recherche des Cordeliers, Paris, France; Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Université Pierre et Marie Curie, Paris, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Gustave Roussy Cancer Center, Villejuif, France; Department of Surgery, Gustave Roussy Cancer Center, Villejuif, France; Department of Dermatology, Gustave Roussy Cancer Center, Villejuif, France. · INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. Electronic address: · Pubmed 26829031
Universite Paris 11 Sud
2016
  • INSERMU1160, Institut Universitaire d'Hématologie, Hôpital Saint Louis , Paris, France. · Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne , Lausanne, Switzerland. · U1015 INSERM-CIC, Institut Gustave Roussy , Villejuif, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France; University of Paris Sud XI, Kremlin Bicêtre, France. · Inserm U1173 and University of Versailles Saint-Quentin, Montigny-le-Bretonneux, France; APHP, Ambroise Paré Hospital, Division of Genetics, Boulogne-Billancourt, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes , Paris, France. · APHP, Department of Dermatology, Hospital Cochin, University Paris Descartes, Paris, France; Université Pierre et Marie Curie, Paris, France. · U1015 INSERM-CIC, Institut Gustave Roussy, Villejuif, France; University of Paris Sud XI, Kremlin Bicêtre, France; Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), Villejuif, France; INSERM, U1015, GRCC, Villejuif, France; Center of Clinical Investigations in Biotherapies of Cancer, CICBT507, GRCC, Villejuif, France. · Pubmed 28123867
  • Department of Medical Oncology, Georges François Leclerc Center, Dijon, France; Institut National de la Santé et de la Recherche Médicale, Avenir Team INSERM, University of Burgundy, Dijon, France; Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Institut Gustave Roussy, Villejuif, France. · Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; INSERM, U1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; University of Paris Sud XI, Villejuif, France. · Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus , Villejuif, France. · Department of Medical Oncology, Georges François Leclerc Center, Dijon, France; Institut National de la Santé et de la Recherche Médicale, Avenir Team INSERM, University of Burgundy, Dijon, France. · Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Institut Gustave Roussy , Villejuif, France. · Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; INSERM, U1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Department of Pathology, University of Virginia, Charlottesville, VA, USA; Department of Surgery, University of Virginia, Charlottesville, VA, USA. · Department of Surgery, University of Virginia , Charlottesville, VA, USA. · Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Institut Gustave Roussy, Villejuif, France; University of Paris Sud XI, Villejuif, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France. · Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; INSERM, U1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden. · Pubmed 27471635
  • Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Institut National de la Santé et de la Recherche Médicale, U1138, Paris, France; Université Pierre et Marie Curie, Paris, France. · Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Institut National de la Santé et de la Recherche Médicale, U1015, Equipe labellisée Ligue Nationale Contre le Cancer, Villejuif, France; Institut Gustave Roussy Cancer Campus, Villejuif, France; Faculty of Medicine, University of Paris Sud, Kremlin-Bicêtre, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; Institut National de la Santé et de la Recherche Médicale, U1138, Paris, France; Université Pierre et Marie Curie, Paris, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Pubmed 27057431
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
2015
  • Division of Dermatooncology, Department of Dermatology, University Medical Center Tübingen, Germany. Electronic address: · Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Italy. · Gustave Roussy Cancer Campus, Villejuif, France; INSERM U1015, Villejuif, France; Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · Pubmed 25965363
  • Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. · Institut National de la Recherche Agronomique (INRA), Micalis-UMR1319, 78360 Jouy-en-Josas, France. · University of Lille, CNRS, INSERM, Centre Hospitalier Régional Universitaire de Lille, Institut Pasteur de Lille, U1019, UMR 8204, Centre d'Infection et d'Immunité de Lille (CIIL), F-59000 Lille, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Department of Radiation Oncology, New York University, New York, NY, USA. · Microenvironment and Immunity Unit, Institut Pasteur, Paris, France. · Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. · Department of Genetics and Department of Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. · Animalerie Centrale, Institut Pasteur, Paris, France. · Centre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale (IPBS), Toulouse, France. Université de Toulouse, Université Paul Sabatier, IPBS, F-31077 Toulouse, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Service de microbiologie, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Laboratory of Immunomonitoring in Oncology, UMS 3655 CNRS/US 23 INSERM, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. INSERM U981, GRCC, Villejuif, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Metabolomics Platform, GRCC, Villejuif, France. INSERM U848, Villejuif, France. Equipe 11 Labellisée-Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, INSERM U1138, Paris, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France. · Unité des Rickettsies, Faculté de Médecine, Université de la Méditerranée, Marseille, France. · Institut Pasteur, Unit of Biology and Genetics of the Bacterial Cell Wall, Paris, France. INSERM, Equipe Avenir, Paris, France. · University of Paris Sud XI, Kremlin-Bicêtre, France. Gastroenterology Department, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Paris, France. · Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805 Villejuif, France. INSERM U1015, GRCC, Villejuif, France. University of Paris Sud XI, Kremlin-Bicêtre, France. Center of Clinical Investigations in Biotherapies of Cancer 1428, Villejuif, France. · Pubmed 26541610
  • Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. · Institut National de la Santé et de la Recherche Médicale, Paris, France. · Université Pierre et Marie Curie, Paris, France. · Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France. · Institut National de la Santé et de la Recherche Médicale, Equipe labellisée Ligue Nationale Contre le Cancer, Villejuif, France. · Institut Gustave Roussy Cancer Campus, Villejuif, France. · Faculty of Medicine, University of Paris Sud, Kremlin-Bicêtre, France. · Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France. · Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Pubmed 26059437
  • 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507, Villejuif, France. · 1] INSERM, Unité Mixte de Recherche_S959, I, Paris, France [2] Assistance-Publique Hopitaux de Paris, Hôpital Pitié-Salpêtrière, Biotherapy, Paris, France. · INSERM U753, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] Department of Medical Oncology, IGR, Villejuif, France. · Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA. · University of California Los Angeles, Los Angeles, CA, USA. · Ludwig Center for Cancer Immunotherapy, Department of Immunology, and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, Poznan, Poland [2] Chair of Medical Biotechnology, Poznan University of Medical Sciences, Poznan, Poland. · Department of Dermatology, University Hospital Essen, Germany. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Bristol-Myers Squibb, Redwood City, CA, USA. · Earle A Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · 1] QIMR Berghofer Medical Research Institute, Herston, 4006, Queensland, Australia [2] School of Medicine, The University of Queensland, Herston, QLD 4006, Queensland, Australia. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Department of Medical Oncology, IGR, Villejuif, France [4] INSERM U981, Villejuif, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U848, Villejuif, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France [4] Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, INSERM U 1138, Paris, France [5] Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France [6] Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · 1] Gustave Roussy Cancer Campus, Villejuif, France [2] INSERM U1015, Villejuif, France [3] Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France [4] Department of Medical Oncology, IGR, Villejuif, France. · Pubmed 25582080
2014
  • Laboratorio de Pesquisa em Células Inflamatórias e Neoplásicas Group, Universidade Federal do Paraná, Curitiba, Paraná, Brazil. Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM U1015, Villejuif, France. Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. · Signal Transduction Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Bone Marrow Transplant Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · Department of Immunology, Juntendo University School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan. · Gustave Roussy Cancer Campus, Villejuif, France. INSERM U1015, Villejuif, France. Université Paris Sud-XI, Faculté de Médecine, Le Kremlin Bicêtre, France. Department of Medical Oncology, IGR, Villejuif, France. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Pubmed 25351955
2018
  • Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia. · Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia. · Gustave Roussy Comprehensive Cancer Institute, Villejuif, France. · INSERM U1015, Villejuif, France. · Faculty of Medicine, Paris Sud/Paris XI University, LeKremlin-Bicêtre, France. · Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. · Pubmed 30420855
2014
  • Authors' Affiliations: Cancer Institute Gustave Roussy; Departments of Epidemiology and Statistics and Dermatology; Stabilité génétique et oncogenèse UMR 8200; Clinical Oncology, Melanoma Branch, Cancer Institute Gustave Roussy; Department of BioPathology, Translational Research Laboratory and Biobank, Institute Gustave Roussy; Institut National de la Santé et de la Recherche Medicale (INSERM), U1015; Center of Clinical Investigations CBT507, Biotherapy, Villejuif; INSERM U1102, Institut de Cancérologie de l'Ouest, Saint Herblain; INSERM, U892, Institut de Recherche Thérapeutique, Nantes; INSERM, U1016, Saint Vincent de Paul Hospital; INSERM U1016, CNRS UMR8104, Cochin Institute; Faculté Paris Sud-Université Paris XI, Paris, France; and IRCCS San Matteo University Hospital Foundation, Pavia, Italy. · Pubmed 24197135
Miscellaneous institutions in Villejuif
2015
  • Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. · Institut National de la Santé et de la Recherche Médicale, Paris, France. · Université Pierre et Marie Curie, Paris, France. · Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France. · Institut National de la Santé et de la Recherche Médicale, Equipe labellisée Ligue Nationale Contre le Cancer, Villejuif, France. · Institut Gustave Roussy Cancer Campus, Villejuif, France. · Faculty of Medicine, University of Paris Sud, Kremlin-Bicêtre, France. · Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France. · Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. · Pubmed 26059437
2018
  • Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia. · Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia. · Gustave Roussy Comprehensive Cancer Institute, Villejuif, France. · INSERM U1015, Villejuif, France. · Faculty of Medicine, Paris Sud/Paris XI University, LeKremlin-Bicêtre, France. · Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France. · Pubmed 30420855
10 Other Locations Show
Yearly article counts 02427543131
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.